|
Table 1: characteristics of study participants at enrollment into the CoLTART study, by sex |
||||
|
Characteristic |
All [N=1024] |
Female [N=669] |
Males [N=355] |
|
|
n (%) |
n (%) |
n (%) |
||
|
Age in years |
18-34 |
111 (10.8) |
86 (12.9) |
25 (7.0) |
|
35-49 |
613 (59.9) |
401 (59.9) |
212 (59.7) |
|
|
50+ |
300 (29.3) |
182 (27.2) |
118 (33.2) |
|
|
Level of education1
|
Incomplete primary/none |
459 (45.0) |
294 (44.0) |
165 (46.7) |
|
Complete primary |
156 (15.3) |
104 (15.6) |
51 (14.7) |
|
|
Secondary + |
406 (39.8) |
270 (40.4) |
136 (38.5) |
|
|
Occupation1
|
Peasant Farmer |
322 (31.6) |
205 (30.7) |
117 (33.1) |
|
Gainful employment |
210 (20.6) |
132 (19.8) |
78 (22.1) |
|
|
Self-employed / business |
408 (40.0) |
264 (39.6) |
144 (40.4) |
|
|
Unemployed |
80 ( 7.8) |
66 ( 9.9 ) |
14 ( 4.0 ) |
|
|
SES Score (tertiles)1
|
Low |
416 (42.1) |
307 (47.8) |
109 (31.6) |
|
Middle |
378 (38.3) |
240 (47.8) |
138 (40.0) |
|
|
High |
193 (19.6) |
95 (14.8) |
98 (28.4) |
|
|
Alcohol consumption1 |
Never |
379 (37.5) |
277 (41.8) |
102 (29.1) |
|
Ever >1 month ago |
366 (36.2) |
252 (38.1) |
114 (32.6) |
|
|
Within < 1 month |
267 (26.4) |
133 (20.1) |
134 (38.3) |
|
|
Animal proteins consumption (days/week) |
0 |
269 (26.6) |
204 (30.8) |
65 (18.5) |
|
1- 2 |
462 (45.6) |
292 (44.1) |
170 (48.4) |
|
|
3+ |
282 (27.8) |
166 (25.1) |
116 (33.0) |
|
|
Tobacco consumption2 |
Never |
843 (82.6) |
625 (93.7) |
218 (61.8) |
|
Ex-smoker |
97 ( 9.5) |
17 ( 2.5 ) |
80 (22.7) |
|
|
Current |
80 ( 7.8) |
25 ( 3.7 ) |
55 (15.6) |
|
|
Physical activity level2 |
Low |
473 (46.4) |
365 (54.7) |
108 (30.7) |
|
Moderate - high |
546 (53.6) |
302 (45.3) |
244 (69.3) |
|
|
Total duration on ART (Years) |
0-<5 |
243 (23.7) |
150 (22.4) |
93 (26.2) |
|
5-<9 |
124 (12.1) |
74 (11.1) |
50 (14.1) |
|
|
9+ |
657 (64.2) |
445 (66.5) |
212 (59.7) |
|
|
ART regimen |
Non PI based ART |
788 (77.0) |
519 (77.6) |
269 (75.8) |
|
PI based ART |
236 (23.0) |
150 (22.4) |
86 (24.2) |
|
|
Cholesterol (>5.2 mol/L) |
No |
708 (69.8) |
442 (66.1) |
266 (75.8) |
|
Yes |
306 (30.2) |
221 (33.3) |
85 (24.2) |
|
|
HDL (<1 mmol/L)3 |
No |
633 (62.4) |
378 (57.0) |
255 (72.6) |
|
Yes |
381 (37.6) |
285 (43.0) |
96 (27.4) |
|
|
LDL (>3.4 mmol/L)3
|
No |
775 (76.4) |
479 (72.2) |
296 (84.3) |
|
Yes |
239 (23.6) |
184 (27.8) |
55 (15.7) |
|
|
Triglycerides (>1.69 mmol/L)3 |
No |
798 (78.8) |
539 (81.3) |
259 (74.0) |
|
Yes |
215 (21.2) |
124 (18.7) |
91 (26.0) |
|
|
Glucose (>6.0 mmol/L) |
No |
979 (96.5) |
640 (96.5) |
339 (96.3) |
|
Yes |
36 ( 3.5) |
23 (3.5 ) |
13 ( 3.7 ) |
|
|
Atherogenic risk (AIP) 4 (log10(triglycerides/HDL) |
No |
696 (68.7) |
482 (72.7) |
214 (61.1) |
|
Yes |
317 (31.3) |
181 (27.3) |
136 (38.9) |
|
|
Body Mass Index (kg/m2)5 |
<18.5 |
103 (10.3) |
54 ( 8.3 ) |
49 (14.1) |
|
18.5–24.9 |
637 (63.6) |
374 (57.2) |
263 (75.6) |
|
|
>25 |
282 (26.1) |
226 (34.6) |
36 (10.3) |
|
|
Waist/hip ratio (WHR) 5 >0.95(men)/>85(women) |
Normal |
478 (47.4) |
207 (31.5) |
271 (77.4) |
|
Abnormal |
530 (52.6) |
451 (68.5) |
79 ( 2.6 ) |
|
|
Hypertension5
|
No |
782 (77.4) |
505 (76.6) |
277 (78.9) |
|
Yes |
228 (22.6) |
154 (23.4) |
74 (21.1) |
|
|
Baseline Viral loads6 (copies/ml)
|
< 1000 |
813 (82.1) |
535 (82.8) |
278 (80.8) |
|
1000 – 10,000 |
53 (5.35) |
39 ( 6.0 ) |
14 ( 4.1 ) |
|
|
>10,000 |
124 (12.5) |
72 (11.2) |
52 (15.1) |
|
|
Baseline CD4 cell counts6 (cells/ml)
|
< 350 |
300 (31.5) |
163 (24.5) |
137 (40.5) |
|
351 – 500 |
294 (30.8) |
191 (31.0) |
103 (30.5) |
|
|
> 500 |
360 (37.7) |
262 (42.5) |
98 (29.0) |
|
|
Data was missing on; SES1-(27 women and 10 men), occupation1 (2 women and 1 man), Level of education1(1 woman and 3 men), consumption of Alcohol1 and animal protein1 (7 women and 5 men). Data was missing for; Tobacco consumption2 (2 women and 2 men) and Physical activity2 (2 women and 3 men). Data was Missing on; Serum Tc3, HDL3 LDL3, TG3 Glucose (6 women and 4 men). Calculation of AIP4 excluded 6 women and 3 men with missing data. There was missing data on; HT5 (10 Women and 4 men) BMI5 (15 women and 7 men), WHR5 and WC (11 women and 5 men), Baseline VL6 (23 women and 11 men) and Baseline CD4 cell count6 ( 53 women, 7 men) |
||||